1. Home
  2. GNLX vs SCOR Comparison

GNLX vs SCOR Comparison

Compare GNLX & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.52

Market Cap

113.6M

Sector

Health Care

ML Signal

HOLD

Logo comScore Inc.

SCOR

comScore Inc.

N/A

Current Price

$6.83

Market Cap

112.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
GNLX
SCOR
Founded
2001
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
113.6M
112.4M
IPO Year
2022
2007

Fundamental Metrics

Financial Performance
Metric
GNLX
SCOR
Price
$2.52
$6.83
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$17.25
N/A
AVG Volume (30 Days)
210.7K
14.1K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
9.47
127.37
EPS
N/A
4.25
Revenue
$8,000.00
$403,549,000.00
Revenue This Year
N/A
$2.75
Revenue Next Year
N/A
$7.30
P/E Ratio
N/A
$1.61
Revenue Growth
N/A
1.02
52 Week Low
$2.26
$4.39
52 Week High
$8.54
$10.18

Technical Indicators

Market Signals
Indicator
GNLX
SCOR
Relative Strength Index (RSI) 44.99 43.84
Support Level $2.30 $6.22
Resistance Level $2.97 $7.18
Average True Range (ATR) 0.21 0.51
MACD -0.01 -0.06
Stochastic Oscillator 37.29 12.02

Price Performance

Historical Comparison
GNLX
SCOR

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

About SCOR comScore Inc.

comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.

Share on Social Networks: